Detalhe da pesquisa
1.
Use of Phenotypically Poor Metabolizer Individual Donor Human Liver Microsomes To Identify Selective Substrates of UGT2B10.
Drug Metab Dispos
; 48(3): 176-186, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31839590
2.
Simultaneous Assessment of Clearance, Metabolism, Induction, and Drug-Drug Interaction Potential Using a Long-Term In Vitro Liver Model for a Novel Hepatitis B Virus Inhibitor.
J Pharmacol Exp Ther
; 365(2): 237-248, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29453199
3.
Correction to: In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human Hepatocytes.
AAPS J
; 22(6): 142, 2020 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156404
4.
In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human Hepatocytes.
AAPS J
; 22(6): 131, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33051808
5.
Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies.
AAPS J
; 21(5): 77, 2019 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31214810
6.
Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling.
AAPS J
; 19(2): 534-550, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28050713
7.
Hydrophilic interaction chromatography of intact, soluble proteins.
J Chromatogr A
; 1218(35): 5892-6, 2011 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20926084